This study assesses the domestic water supply status, physicochemical quality, and associated health risks in a region reliant on groundwater-derived tap water. A cross-sectional survey revealed that 89% of households depend on tap water, yet 78% express significant concerns about its safety, prompting inconsistent treatment practices (45% treat water “seldom”). Physicochemical analysis of tap water samples identified critical contamination issues: 33.3% of samples exceeded Bangladesh (BD ECR 2023) iron (Fe) limits (0.3-2.05 mg/L), while 100% surpassed WHO guidelines (0.3 mg/L). Manganese (Mn) exceeded permissible levels (0.1 mg/L) in 33.3% of samples. Total coliform contamination (up to 12 CFU/100ml) was widespread, though fecal coliforms were absent. Principal Component Analysis (PCA) attributed 82.22% of water quality variance to dissolved solids (electrical conductivity, salinity) and metal contamination (Fe, Mn), linked to geogenic/anthropogenic sources. Health risk assessments revealed non-carcinogenic hazards, particularly for children, with Hazard Index (HI) values reaching 2.87-far exceeding the safety threshold (HI > 1). Iron posed the greatest risk (THQ up to 2.44 for children), underscoring vulnerabilities due to physiological sensitivity. Despite 67% of respondents reporting satisfaction with water quality, stark disparities exist between perception and analytical results, driven by aesthetic/metallic concerns. Urgent interventions are needed, including infrastructure upgrades to curb pipe corrosion, advanced metal removal filtration, and community water treatment education. Policymakers must prioritize stricter industrial regulations and routine monitoring. This study highlights the imperative to align public trust with scientific evidence to safeguard health in groundwater-dependent communities.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors